DOD FY11 Tuberous Sclerosis Complex Clinical Trial Award

archived

The Tuberous Sclerosis Complex Research Program (TSCRP) was established in 2002 to promote innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC). The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis of TSC, and to translate these findings to the care of individuals with TSC. The TSCRP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of TSC. Funding from this award mechanism must support a clinical trial and cannot be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction.

High